Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2012

View Archived Issues

Negative findings reported from LEAP study of CO-101

Novel biguanide inhibits cell proliferation and cyst growth of human ADPKD cells

Vertex presents in vitro results for a novel CFTR corrector

Nerviano Medical Sciences patents novel protein kinase inhibitors

GlaxoSmithKline discloses new TRPV1 antagonists

French team synthesizes novel ALK tyrosine kinase receptor inhibitors

New S1P1 receptor agonists presented by French and Indian researchers

Bayer Intellectual Property divulges novel GCS activators

Laboratoire Biodim prepares new anti-HIV agents

Promising phase I results presented for myrcludex B

Immunomic Therapeutics begins phase I study of JRC-LAMP-vax vaccine

Phase III pancreatic cancer study of Abraxane meets primary endpoint

Astellas partners with Japanese universities for antiprotozoan drugs

FDA approves Prezista 800-mg tablets for the treatment of HIV

Novartis files supplemental NDA for Neoral in Japan

China's State Food and Drug Administration approves first-in-human trial of APX-003

RedHill Biopharma concludes pre-NDA meeting with FDA for RHB-103

PATH's Drug Development program to advance antidiarrheal candidate

Phase I/IIa study of RPh-201 in chronic vegetative patients begins in Israel

FDA advisory committee schedules review of Zohydro

Advanced Cell Technology reports interim clinical data on hESC-derived RPE cells

Interim results presented for a peptide-based cancer vaccine

U.S. screening begins for new phase Ib study of PRTX-100

First patient receives NiCord stem cell transplant in pilot study

Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...